mefloquine is useful for the prevention of malaria in all areas except for those where parasites may have resistance to multiple medications , and is one of several anti-malarial medications recommended by the united states centers for disease control and prevention for this purpose it is also recommended by the infectious disease society of america for malaria prophylaxis as a first or second-line agent , depending on resistance patterns in the malaria found in the geographic region visited if a person becomes ill with malaria despite prophylaxis with mefloquine , the use of halofantrine and quinine for treatment may be ineffective mefloquine is used as a treatment for chloroquine-sensitive or resistant plasmodium falciparum malaria , and is deemed a reasonable alternative for uncomplicated chloroquine-resistant plasmodium vivax malaria mefloquine does not eliminate parasites in the liver phase of the disease , and people with p vivax malaria should be treated with a second drug that is effective for the liver phase , such as primaquine severe side effects requiring hospitalization are rare , but include mental health problems such as depression , hallucinations , anxiety and neurological side effects such as ataxia , seizures , and tinnitus food and drug administration ( fda ) added a boxed warning to the prescription label of mefloquine regarding the potential for neuropsychiatric side effects that may persist even after discontinuing administration of the medication in 2013 the fda stated '' neurologic side effects can occur at any time during drug use , and can last for months to years after the drug is stopped or can be permanent central nervous system events requiring hospitalization occur in about one in 10,000 people taking mefloquine for malaria prevention , with milder events ( e.g combining mefloquine with other drugs that cause similar effects , such as quinine or quinidine , can increase these effects mefloquine is also safe and effective for use during breastfeeding , though it appears in breast milk in low concentrations the world health organization ( who ) gives approval for the use of mefloquine in the second and third trimesters of pregnancy and use in the first trimester does not mandate termination of pregnancy the mean elimination plasma half-life of mefloquine is between two and four weeks in 2006 , the australian military deemed mefloquine '' a third-line drug '' alternative , and over the five years from 2011 only 25 soldiers had been prescribed the drug , and only in cases of their intolerance for other alternatives wrair has published several papers outlining ongoing efforts at that institution to make mefloquine safer by producing a drug composed of only the ( + ) -enantiomer 